Why this matters — Four distinct ORTEX data signals have converged on SCNI (Scinai Immunotherapeutics) within days, pointing to an extreme and rapidly escalating short-side stress event. Short interest, utilization, and cost to borrow have all moved simultaneously and sharply, while the stock itself surged 61.6% in a single session.
Short Interest Tripled in One Week. SI % of Free Float rose from ~2.2% to 5.95% — a 170% weekly increase. Shares short stood at 227,551 as of April 24, up 238% over the past month. The acceleration is steep: the position was largely stable below 90,000 shares through mid-March before ramping hard.
Cost to Borrow Exploded Overnight. CTB sat below 5.5% for the entire prior month. On April 24 it jumped to 148.2% — a single-day move of roughly 2,200%. The one-week change registers +2,786%. Borrowing SCNI shares is now materially expensive, a direct signal of supply tightness in the lending market.
Utilization at 52-Week Peak. Utilization hit 96.84% on April 23 — the highest level recorded in the past year — and held at 96.33% on April 24. Prior to April 22, utilization had been range-bound between 34% and 78%. The near-vertical move to near-100% means almost all available lendable shares are now out on loan.
Stock Surged 61.6% in One Day. The price closed at $0.737 on April 24, up 61.6% on the day and up 32.8% over the week. The price move alongside rising short interest and near-100% utilization indicates significant dislocation between supply of borrowable shares and demand to cover or establish new positions.
SCNI's ORTEX utilization rank stands at the 2nd percentile globally — meaning almost no stock has higher utilization relative to its peer universe. The combined ORTEX score is 69.6, with the short score at 59.2 as of April 23. Amir Reichman, listed among the top holders, added 11,434 shares as recently as Q1 2026. Daniel Stone — the largest disclosed holder at 7.4% of shares — added 42,800 shares in the period ending December 31, 2025. An earnings event is scheduled for May 11, 2026, adding a near-term catalyst to an already compressed short setup.
A brief precedent exists within SCNI's own history. On April 1, 2026, shares short briefly spiked to ~239,865 before collapsing back to ~85,000 the following session. That episode did not produce the same CTB or utilization response seen now, suggesting the current dislocation is more structurally acute.
See the live data behind this article on ORTEX.
Open SCNI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
